Valuation: DocMorris AG

Market Cap 45Cr 56Cr 49Cr 42Cr 80Cr 5.36TCr 81Cr 541.92Cr 211.12Cr 2.63TCr 211.26Cr 206.72Cr 9.08TCr P/E 2026 *
-5.82x
P/E 2027 * -11.1x
Enterprise Value 65Cr 81Cr 71Cr 61Cr 115.42Cr 7.74TCr 117.18Cr 783.07Cr 305.06Cr 3.8TCr 305.28Cr 298.71Cr 13TCr EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.5x
Free-Float
66.58%
Yield 2026 *
-
Yield 2027 * -
1 year 7.45
Extreme 7.454
10.24
3 years 7.45
Extreme 7.454
108.05
5 years 7.45
Extreme 7.454
425
10 years 7.45
Extreme 7.454
547
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 68 28/04/2022
Director/Board Member 53 23/05/2019
Director/Board Member 56 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-27.18%-.--% - - 56Cr
+5.68%+12.88%-13.01%-31.17% 1.47TCr
+4.44%+7.17%-22.04%-32.44% 678.07Cr
+0.52%+0.80%-17.24%-10.88% 586.51Cr
+3.58%+9.79%-20.13%-33.45% 356.52Cr
+3.52%+7.91%-35.58%-9.07% 343.64Cr
+0.32%-0.05%-27.97%-45.41% 324.52Cr
+4.67%+15.20%+1.67%-37.08% 286.07Cr
-0.31%-0.73%+101.44% - 265.95Cr
-0.34%-2.60%+0.52%+37.81% 172.07Cr
Average -0.51%+4.85%-3.59%-20.21% 498.19Cr
Weighted average by Cap. +3.07%+7.09%-10.06%-25.63%

Financials

2026 *2027 *
Net sales 121.95Cr 151.7Cr 132.61Cr 113.61Cr 215.41Cr 14TCr 218.69Cr 1.46TCr 569.33Cr 7.1TCr 569.74Cr 557.47Cr 24TCr 137.12Cr 170.56Cr 149.1Cr 127.74Cr 242.19Cr 16TCr 245.88Cr 1.64TCr 640.12Cr 7.98TCr 640.57Cr 626.78Cr 28TCr
Net income -8.35Cr -10Cr -9.08Cr -7.78Cr -15Cr -989.51Cr -15Cr -100.07Cr -39Cr -486.22Cr -39Cr -38Cr -1.68TCr -4.68Cr -5.82Cr -5.09Cr -4.36Cr -8.26Cr -554.4Cr -8.39Cr -56Cr -22Cr -272.42Cr -22Cr -21Cr -939.61Cr
Net Debt 20Cr 25Cr 22Cr 19Cr 36Cr 2.38TCr 36Cr 241.15Cr 94Cr 1.17TCr 94Cr 92Cr 4.04TCr 24Cr 30Cr 26Cr 22Cr 42Cr 2.83TCr 43Cr 285.7Cr 111.3Cr 1.39TCr 111.38Cr 108.98Cr 4.79TCr
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
1,337
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
9.250CHF
Average target price
7.756CHF
Spread / Average Target
-16.15%

Quarterly revenue - Rate of surprise